e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 57

Detection of circulating tumor cells in colorectal cancer patients using the GILUPI CellCollector: results from a prospective, single‐center study

Levent Dizdar; Georg Fluegen; Guus van Dalum; Ellen Honisch; Rui P. Neves; Dieter Niederacher; Hans Neubauer; Tanja Fehm · 2019 · Molecular Oncology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

The GILUPI CellCollector (CC) is a novel in vivo circulating tumor cell (CTC) detection device reported to overcome the limitations of small blood sample volumes. The aim of this prospective, blinded study was to evaluate the clinical application of the CC and to compare its performance to the CellSearch (CS) system in M0 and M1 colorectal cancer (CRC) patients. A total of 80 patients (31 M0, 49 M1) with CRC were enrolled. CTCs were simultaneously measured in the peripheral blood using CS and the CC, and the results of both assays were correlated to clinicopathological variables and overall su

Abstract by Levent Dizdar; Georg Fluegen; Guus van Dalum; Ellen Honisch; Rui P. Neves; Dieter Niederacher; Hans Neubauer; Tanja Fehm, Molecular Oncology (2019) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1002/1878-0261.12507